Venture-Backed Startups
71,815 companies with verified investor relationships.
AtTimeT builds predictive models for financial markets using mathematical approaches to anticipate large-scale market behavior. The company applies advanced intelligence techniques to asset management and financial decision-making.
1 investor
Attio provides an AI-powered agent platform that automates prospecting and lead research for sales teams, enriching leads and qualifying them so sales representatives can focus on closing deals.
5 investors
Web3 SEO and content marketing services for crypto, blockchain, DeFi, and NFT brands.
1 investor
0 investors
0 investors
0 investors
Attivare develops AI-powered personalized immunotherapy treatments using a proprietary biomaterial scaffold (ATTImmune) that delivers immune agonists directly to tumor microenvironments, aiming to reduce systemic toxicity in cancer and infectious disease treatment.
1 investor
0 investors
Commvault provides a cloud-native data resilience platform that unifies security, governance, identity management, and data recovery capabilities for enterprise organizations. The platform protects and recovers data across all environments while defending against ransomware and cyberattacks.
1 investor
0 investors
0 investors
Attn: Grace designs and manufactures plant-based, skin-safe incontinence products for women, manufactured in carbon-neutral facilities. The company focuses on preventing skin irritation and improving quality of life for the 19 million women in the U.S. experiencing bladder leaks.
11 investors
0 investors
Attolight manufactures cathodoluminescence instruments for materials characterization and semiconductor defect inspection, serving semiconductor companies and research institutes. The company develops spectroscopic SEM platforms and automated wafer inspection systems for advanced materials analysis.
1 investor
0 investors
AttoTude develops optical interconnect technology for data centers to support artificial intelligence and exascale computing applications.
2 investors
Attovia develops precision biologics using its ATTOBODY platform for patients with immune-mediated diseases. The company creates novel complex biologic medicines through modular protein design.
6 investors
3 investors
1 investor
Attune provides software supply chain security by enabling traceability of code back to its author, device, and keystroke to prevent CI/CD pipeline attacks and secure the build process.
2 investors
0 investors
1 investor
Attune Health combines genomics, proteomics, and metabolomics with functional nutrition and lifestyle modification to treat people with autoimmune and inflammatory diseases. The company leverages precision science and technology to improve patient outcomes in this healthcare sector.
1 investor
2 investors